Daratumumab, bortezomib, lenalidomide and dexamethasone for the treatment of multiple myeloma.
CL202600944A1Pending Publication Date: 2026-07-31JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600944
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-07-31
- Filing Date
- 2026-03-27
- Publication Date
- 2026-07-31
Abstract
This disclosure relates to methods for the treatment of, for example, newly diagnosed multiple myeloma.
Need to check novelty before this filing date? Find Prior Art